Synthesis, Molecular Dynamics Simulation, and In-vitro Antitumor Activity of Quinazoline-2,4,6-triamine Derivatives as Novel EGFR Tyrosine Kinase Inhibitors.

Nili Ahmadabadi M, Rezaee E, Nematpour M, Karami L, Mokhtari S, Kobarfard F, Tabatabai SA

Open source

DOI
10.5812/ijpr-133840
Published
2022 Dec
Container
Iranian journal of pharmaceutical research : IJPR
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.5812/ijpr-133840,
  title = {Synthesis, Molecular Dynamics Simulation, and In-vitro Antitumor Activity of Quinazoline-2,4,6-triamine Derivatives as Novel EGFR Tyrosine Kinase Inhibitors.},
  author = {Nili Ahmadabadi M and Rezaee E and Nematpour M and Karami L and Mokhtari S and Kobarfard F and Tabatabai SA},
  year = {2022},
  journal = {Iranian journal of pharmaceutical research : IJPR},
  doi = {10.5812/ijpr-133840},
  url = {https://doi.org/10.5812/ijpr-133840}
}

RIS

TY  - JOUR
TI  - Synthesis, Molecular Dynamics Simulation, and In-vitro Antitumor Activity of Quinazoline-2,4,6-triamine Derivatives as Novel EGFR Tyrosine Kinase Inhibitors.
AU  - Nili Ahmadabadi M
AU  - Rezaee E
AU  - Nematpour M
AU  - Karami L
AU  - Mokhtari S
AU  - Kobarfard F
AU  - Tabatabai SA
PY  - 2022
JO  - Iranian journal of pharmaceutical research : IJPR
DO  - 10.5812/ijpr-133840
UR  - https://doi.org/10.5812/ijpr-133840
ER  - 

APA

M, N. A., E, R., M, N., L, K., S, M., F, K., & SA, T. (2022). Synthesis, Molecular Dynamics Simulation, and In-vitro Antitumor Activity of Quinazoline-2,4,6-triamine Derivatives as Novel EGFR Tyrosine Kinase Inhibitors.. Iranian journal of pharmaceutical research : IJPR. https://doi.org/10.5812/ijpr-133840

Source records